| Cat.No. | Name | Information |
|---|---|---|
| M58368 | GTPγS tetralithium | GTPγS (tetralithium) is a G-protein activator that protects proteins from proteolytic degradation, stimulates GLUT4 translocation in a tyrosine kinase-dependent manner, stimulate phospholipases and induce actin polymerization. GTPγS (tetralithium) acts as a component of lysis buffer. |
| M54563 | GLUT inhibitor-1 | GLUT inhibitor-1 is a potent and orally active glucose transporter protein (GLUT) inhibitor that targets GLUT1 and GLUT3 with IC50 values of 242 nM and 179 nM, respectively.GLUT inhibitor-1 can be used in cancer and autoimmune disease related studies. |
| M28266 | KL-11743 | KL-11743 is a potent, orally active, and glucose-competitive inhibitor of the class I glucose transporters, with IC50s of 115, 137, 90, and 68 nM for GLUT1, GLUT2, GLUT3, and GLUT4, respectively. KL-11743 specifically blocks glucose metabolism. KL-11743 can synergize with electron transport inhibitors to induce cell death. |
| M20762 | DRB18 | DRB18 is a pan-GLUT (glucose transporters) inhibitor that inhibits growth and proliferation in several different cancer cells. |
| M16986 | Kobusin | Kobusin, a dioxygenated lignan isolated from Pnonobio biondii Pamp, is also an activator of the CFTR and CaCCgie chloride channels and an inhibitor of the ANO1/CaCC (calcium-activated chloride channel) channel. |
| M8661 | BAY-588 | BAY-588 is an inactive control probe for BAY-876. |
| M8659 | BAY-876 | BAY-876 is a potent, highly selective, cell-permeable inhibitor of glucose transporter GLUT1 with an IC50 of 2 nM. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth. BAY-876 can induce the formation of disulfide bonds in actin cytoskeletal proteins, leading to the occurrence of cellular disulfidptosis. |
| M7744 | Dihydrokainic acid | Dihydrokainic acid is a selective inhibitor of the GLT-1 glutamate transporter. |
| M6316 | 1,9-Dideoxyforskolin | 1,9-Dideoxyforskolin is a inactive analog of forskolin |
| M6156 | WZB117 | WZB117 is an inhibitor of Glucose Transporter 1 (GLUT1). It inhibited cell proliferation in lung cancer A549 cells and breast cancer MCF7 cells with an IC50 of approximately 10 μM. |
| M4970 | STF-31 | STF-31 is a selective glucose transporter GLUT1 inhibitor, with an IC50 of 1 μM. STF-31 is also a NAMPT inhibitor. |
| M56490 | SW157765 | SW157765 is a selective non-canonical glucose transporter GLUT8 (SLC2A8) inhibitor. |
| M42196 | SLC26A3-IN-3 | SLC26A3-IN-3 is a SLC26A3 inhibitor (IC50: 40 nM). |
| M42195 | MSNBA | MSNBA is a specific inhibitor of GLUT5 fructose transport in proteoliposomes. |
| M42194 | SLC26A3-IN-1 | SLC26A3-IN-1 is an inhibitor of anion exchanger protein SLC26A3 (IC50=340 nM). |
| M42193 | SLC26A3-IN-2 | SLC26A3-IN-2 is an orally active inhibitor of anion exchanger protein SLC26A3 (IC50=360 nM). |
| M42192 | MMV009085 | MMV009085 is a potent PfHT1 (Plasmodium falciparum hexose transporter)-specific inhibitor and a potential anti-malarial agent . |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
